Clinical Trials Directory

Trials / Completed

CompletedNCT04453579

Bariatric Surgery During Lockdown, Impact of COVID-19 on Physical and Mental Health

Was it Right to Stop Bariatric Surgery During COVID-19 Lockdown?

Status
Completed
Phase
Study type
Observational
Enrollment
116 (actual)
Sponsor
University of Rome Tor Vergata · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

From the beginning of March 2020, lockdown regimens prevented patients with obesity from receiving bariatric surgery. Surgical emergencies and oncological procedures were the only operations allowed in public hospitals. Consequently, patients with morbid obesity were put in a stand-by situation. With the aim at exploring physical and psychological conditions of the investigators future bariatric surgery patients, the investigators built a Questionnaire concerning obesity and COVID-19.

Detailed description

Introduction: the investigators present an investigation about the impact of COVID-19 on individuals suffering from severe obesity that were in the waiting list for bariatric surgery. Worldwide and in Italy bariatric procedures are considered as elective surgery and therefore were interrupted during the lockdown. The patients are well-known victim of stigma, social discrimination and the majority of them is affected by maladaptive eating behaviors that are supposed to worsen due to the isolation, absence of healthcare check-up and alarming pandemic scenario.the investigators performed telephonic interview providing an ad hoc questionnaire with the aim to explore their emotional and physical status. Method: A total of 116 bariatric surgery candidates were approached using a telephonic interview during the Italian lockdown.

Conditions

Interventions

TypeNameDescription
BEHAVIORALTelephonic interview during the Italian lockdown.The interview was composed of socio-demographic items lockdown, and dichotomous questions about physical and mental health in relation to the COVID-19 emergency

Timeline

Start date
2020-03-09
Primary completion
2020-05-04
Completion
2020-05-30
First posted
2020-07-01
Last updated
2020-07-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04453579. Inclusion in this directory is not an endorsement.